Kirila Trifonova Stoynova

Dr. Kirila Trifonova Stoynova

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
MTMina Todorova
Mina Todorova
RBRumyana Ivanova Bakalska
Rumyana Ivanova Bakalska
Mehran Feizi-DehnayebiMehran Feizi-Dehnayebi
Mehran Feizi-Dehnayebi
Ghodsi Mohammadi ZiaraniGhodsi Mohammadi Ziarani
Ghodsi Mohammadi Ziarani
MPMina Miroslavova Pencheva
Mina Miroslavova Pencheva
Stoyanka Atanasova NikolovaStoyanka Atanasova Nikolova
Stoyanka Atanasova Nikolova
Stilbenes, like resveratrol, are natural small molecules with several applications in the treatment of chronic illnesses, diabetes, and neurological and cardiovascular conditions. Considering the molecular structure of stilbenes and the biological activities of resveratrol, we investigated the synthesis and biological activity of a novel styryl quinolinium (SQ) derivative. The SQ was synthesized using the alkylation of lepidine and methyl 4-methylbenzenesulfonate and further Knoevenagel condensation with 2-hydroxy naphthaldehyde. Its structure was determined using NMR, IR, Raman, UV-Vis, and MS. The current trend of research has shifted toward the synthesis of novel SQ as resveratrol’s analog. Therefore, its anti-inflammatory and antioxidant activities were evaluated. The compound exerted very good anti-inflammatory effects in preventing albumin denaturation, which were confirmed by ex vivo immunohistochemical studies. Density functional theory (DFT) analyses were conducted on the SQ structure to gain detailed insights into its active sites, energy gap, quantum properties, and electronic behavior. The biological evaluation of the compound was completed, assessing its antioxidant potential using DPPH radical scavenging assay. In addition, molecular docking simulations were utilized to assess the SQ compound’s potential inhibitory effect on human serum albumin (HSA).

12 March 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MSMihaela Stoyanova Stoyanova
Mihaela Stoyanova Stoyanova
Miglena MilushevaMiglena Milusheva
Miglena Milusheva
Milena GeorgievaMilena Georgieva
Milena Georgieva
PIPenyo Ivanov
Penyo Ivanov
GMGeorge Miloshev
George Miloshev
Stoyanka Atanasova NikolovaStoyanka Atanasova Nikolova
Stoyanka Atanasova Nikolova
Background: Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder with a complex pathogenesis that necessitates innovative therapeutic approaches for effective management. Among the commonly used treatments, mebeverine (MBH), an antispasmodic, is widely prescribed to alleviate IBS symptoms. However, challenges in delivering the drug precisely to the colonic region often hinder its therapeutic effectiveness. To address this limitation, silver nanoparticles (AgNPs) have emerged as promising drug delivery systems, offering unique physicochemical properties that can enhance the precision and efficacy of IBS treatments. Objectives: This study aimed to synthesize AgNPs as drug delivery vehicles for MBH and a previously reported analog. The research focused on evaluating the cytotoxic and genotoxic effects of the AgNPs and forecasting their possibly harmful effects on future sustainable development. Methods: AgNPs were synthesized using a rapid method and functionalized with MBH and its analog. The nanoparticles were characterized using different techniques. Cytotoxicity and genotoxicity were evaluated in vitro. Additionally, in silico docking analyses were performed to explore their safety profile further. Results: In vitro assays revealed concentration-dependent cytotoxic effects and a lack of genotoxic effects with MBH-loaded AgNPs. A molecular docking simulation was performed to confirm this effect. Conclusions: The study underscores the potential of AgNPs as advanced drug delivery systems for safe and significant therapeutic implications for IBS. Future in vivo and preclinical investigations are essential to validate the safe range of exposure doses and evaluation standards for assessing AgNPs’ safety in targeted and personalized medicine.

1 January 2015 in Journal of the Serbian Chemical Society
Verified
Journal Article
Open access
VDVidka Vassileva Divarova
Vidka Vassileva Divarova
Kirila Trifonova StoynovaKirila Trifonova Stoynova
Kirila Trifonova Stoynova
PRPetya Racheva
Petya Racheva
VLVanya Lekova
Vanya Lekova
ADAtanas Dimitrov
Atanas Dimitrov
The formation and liquid-liquid extraction of ion-association complexes between Co(II)-4-(2-Pyridylazo)resorcinol (PAR) anionic chelates and cations of three ditetrazolium chlorides were studied: Blue Tetrazolium chloride (BTC), Neotetrazolium chloride (NTC) and Nitro Blue Tetrazolium chloride (NBT). The optimum conditions for the formation and solvent extraction of the ion-association comlpex chelates were determined. It has been found that in the systems of Co(II)-PAR-DTS, the reactants are reacted in molar ratios 1:2:1 and the general formula of complexes was suggested. The extraction equilibria were investigated and quantitatively characterized by the equilibrium constants and the recovery factors. The analytical characteristics of the complexes were calculated.

12 October 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
MSMihaela Stoyanova Stoyanova
Mihaela Stoyanova Stoyanova
Miglena MilushevaMiglena Milusheva
Miglena Milusheva
Vera Nikolaeva GledachevaVera Nikolaeva Gledacheva
Vera Nikolaeva Gledacheva
Iliyana Dimitrova StefanovaIliyana Dimitrova Stefanova
Iliyana Dimitrova Stefanova
MTMina Todorova
Mina Todorova
Stoyanka Atanasova NikolovaStoyanka Atanasova Nikolova
Stoyanka Atanasova Nikolova
Background: Irritable bowel syndrome (IBS) has a major negative influence on quality of life, causing cramps, stomach pain, bloating, constipation, etc. Antispasmodics have varying degrees of efficacy. Mebeverine, for example, works by controlling bowel movements and relaxing the muscles of the intestines but has side effects. Therefore, more efficient medication is required. Methods: In the current study, we investigated the synthesis of novel mebeverine analogs and determined ex vivo their spasmolytic and in vitro and ex vivo anti-inflammatory properties. The ability to influence both contractility and inflammation provides a dual-action approach, offering a comprehensive solution for the prevention and treatment of both conditions. Results: The results showed that all the compounds have better spasmolytic activity than mebeverine and good anti-inflammatory potential. Among the tested compounds, 3, 4a, and 4b have been pointed out as the most active in all the studies conducted. To understand their mechanism of activity, molecular docking simulation was investigated. The docking analysis explained the biological activities with their calculated Gibbs energies and possibilities for binding both centers of albumin. Moreover, the calculations showed that molecules can bind also the two muscarinic receptors and interleukin-β, hence these structures would exert a positive therapeutic effect owed to interaction with these specific receptors/cytokine. Conclusions: Three of the tested compounds have emerged as the most active and effective in all the studies conducted. Future in vivo and preclinical experiments will contribute to the establishment of these novel mebeverine derivatives as potential drug candidates against inflammatory diseases in the gastrointestinal tract.

1 January 2015 in Croatica Chemica Acta
Verified
Journal Article
Open access
PRPetya Racheva
Petya Racheva
Kirila Trifonova StoynovaKirila Trifonova Stoynova
Kirila Trifonova Stoynova
VLVanya Dimitrova Lekova
Vanya Dimitrova Lekova
ADAtanas Nikolov Dimitrov
Atanas Nikolov Dimitrov
The formation and liquid-liquid extraction of ion-association complex between gallium(III) − 4-(2-pyridylazo)-resorcinol (PAR) – 1,4-diphenyl-3-(phenylamino)-1H-1,2,4-triazole (nitron, Nt), water and chloroform were studied. The optimum conditions for gallium(III) extraction as an ion-association complex, (NtH)+[Ga3+(PAR)2]-, were found: pH, concentration of the reagents and shaking time. The following key constants were calculated: constant of extraction (logKex = 6.28 ± 0.07), constant of association (logβ = 4.98 ± 0.05), constant of distribution (logKD = 1.30 ± 0.02) and recovery factor (R / % = 95.17 ± 0.02). Beerʼs law is obeyed for Ga(III) concentration up to 0.8 μg cm-3 with apparent molar absorptivity of (10.3 ± 0.4)×104 dm-3 mol-1 cm-1 at λmax = 510 nm. Some additional characteristics, such as limit of detection (LOD = 0.072 μg cm-3), limit of quantification (LOQ = 0.24 μg cm-3) and Sandellʼs sensitivity (SS = 0.000675 ng cm-2) were estimated as well

16 November 2015 in Journal of Applied Spectroscopy
Verified
Journal Article
Closed access
PDF file
Kirila Trifonova StoynovaKirila Trifonova Stoynova
Kirila Trifonova Stoynova
VDV. V. Divarov
V. V. Divarov
PRPetya Racheva
Petya Racheva
VLV. D. Lekova
V. D. Lekova